NUS study reveals key mechanisms behind drug resistance in relapsed acute myeloid leukemia

Scientists from the National University of Singapore (NUS) have discovered that the evasion of apoptosis is a key driver of drug resistance in patients with relapsed acute myeloid leukaemia (AML), a type of aggressive blood cancer.

The Healing Company Appoints Biotech Visionaries Dr. Linda Friedland and Dr. Peter Kash as Advisors | Psychedelic Invest

The Healing Company Inc. (OTCQB: HLCO) (“The Healing Company” or the “Company”) today announced the appointment of renowned biotech entrepreneurs and investors, Dr. Linda Friedland and

September 7, 2023

FDA approves J&J and Legend’s Carvykti for second-line multiple myeloma

The FDA has expanded the label for Johnson & Johnson and Legend Biotech’s multiple myeloma CAR-T therapy to make it a much earlier treatment option

April 7, 2024

How an ER doctor in Chicago is tackling trauma from gun violence

Abdullah Pratt was only ever interested in science and in sports because of his older brother Rashad. He saw his brother excel at what he

October 20, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.